CHU Orléans
Orléans, 45067, France
Location status: Recruiting
NCT Number: NCT07357181
This prospective, single-center observational study evaluates whether handedness is associated with upper-limb motor recovery after a recent unilateral stroke. Adults admitted to the stroke unit with a confirmed unilateral stroke within 5 days are included if they do not object to participation. Upper-limb impairment is assessed early after stroke and at 6 months using standardized clinical scales. Handedness is determined by self-report, and the Edinburgh Handedness Inventory is administered when feasible. The main hypothesis is that left-handed participants may show better upper-limb motor recovery at 6 months than right-handed participants, potentially due to differences in brain motor network lateralization.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Orléans, 45067, France
Location status: Recruiting
Participants hospitalized in the stroke unit with a confirmed unilateral stroke are recruited consecutively. After eligibility verification and absence of objection, baseline data are collected within 5 days post-stroke. Baseline assessments include the Fugl-Meyer Assessment for the Upper Extremity (FMA-UE), the Shoulder Abduction and Finger Extension (SAFE) score, and the National Institutes of Health Stroke Scale (NIHSS) score (post-acute treatment if thrombolysis or thrombectomy was performed). Handedness is recorded after the motor assessments to maintain assessor blinding regarding group membership; the Edinburgh Handedness Inventory is administered when cognitive status allows. A 6-month follow-up is performed during routine post-stroke consultation at the study site, with repeat FMA-UE and SAFE assessments. The primary analysis compares FMA-UE at 6 months between left-handed and right-handed participants among those with baseline FMA-UE less than 66, using propensity score matching (3:1 right-handed to left-handed) accounting for age, baseline motor deficit, lesion side relative to dominance (dominant vs non-dominant hemisphere), and stroke type (ischemic vs hemorrhagic).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will be evaluated at baseline for Edinburgh Handedness Inventory Laterality Quotient. Patients will be seen again at 6 months as part of their standard post-stroke consultation at Orléans University Hospital by a neurologist from the neurology department. In conjunction with this consultation, an assessment specific to this research study of the FMA-UE and SAFE scores will be carried out by a physiotherapist from the department.
Time frame: month 6
Upper-limb motor impairment measured using the Fugl-Meyer Assessment for the Upper Extremity (FMA-UE) at 6 months post-stroke. Scores range from 0 to 66, with higher scores indicating less impairment. Primary analysis is performed among participants with baseline FMA-UE less than 66.
Time frame: Baseline
Score from 0 to 66; the lower the score, the more severe the deficit
Time frame: Baseline
Time frame: Baseline
Score from 0 to 42; the higher the score, the more severe the deficit
Time frame: Baseline
Number of Participants With Upper-Limb Weakness Defined as SAFE Score Less Than 10
Time frame: Baseline
Score from -100 to +100, no notion of severity here since it assesses manual preference (at -100 you are very left-handed and at +100 you are very right-handed)
Time frame: Month 6
Score from 0 to 10; the lower the score, the more severe the deficit.
Interested in participating?
Request InfoCentre Hospitalier Régional d'Orléans
Other
Impact of Manual Preference on Motor Deficits After Stroke
Acronym: HANDISTROKE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07520032
Brain Diseases, Cardiovascular Diseases
Ajman, Ajman Emirate, United Arab Emirates
View Trial DetailsNCT07579871
Apnea, Brain Diseases
Lund, Skåne County, Sweden
View Trial DetailsNCT07698522
Brain Diseases, Cardiovascular Diseases
Salt Lake City, Utah, United States
View Trial DetailsNCT06891690
Adnexal Diseases, Brain Diseases
Poznan, Poland
View Trial Details